Press Releases April 29, 2026 10:30 AM

AOI Awarded $20.9M Texas Semiconductor Innovation Fund Grant to Advance Manufacturing in Sugar Land

Applied Optoelectronics Secures $20.9M Texas Grant to Expand Semiconductor Manufacturing for AI Data Centers

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
AAOI

Applied Optoelectronics Inc. (NASDAQ: AAOI) announced it has been awarded a $20.85 million grant from the Texas Semiconductor Innovation Fund to support its expansion plans in Sugar Land, Texas. The company will expand its manufacturing capacity by adding a 210,000-square-foot facility to produce advanced optical transceivers for AI data centers, creating over 500 new jobs. This investment reinforces Texas's leadership in semiconductor innovation for AI infrastructure.

AOI Awarded $20.9M Texas Semiconductor Innovation Fund Grant to Advance Manufacturing in Sugar Land
AAOI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • AOI received a $20.85 million grant from the Texas Semiconductor Innovation Fund to support manufacturing expansion.
  • The company plans to add a 210,000-square-foot facility in Sugar Land, Texas, increasing production capacity of AI-focused optical transceivers.
  • Over 500 new high-skilled jobs will be created, strengthening local and national semiconductor and advanced manufacturing sectors.

SUGAR LAND, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics Inc. (NASDAQ: AAOI), a leading provider of advanced optical and HFC networking products powering AI, today announced it was awarded a Texas Semiconductor Innovation Fund (TSIF) grant for $20,852,518 to support the company’s manufacturing expansion plans in Sugar Land, Texas.

“AOI was founded by a team from the University of Houston, and over the intervening 29 years we have expanded in Texas to become a major international…”
“AOI has made great strides here in Texas, helping the world’s largest tech companies define the future of data centers with its optical networking innovation,”
“With this grant, the company can continue to expand here to manufacture the invaluable semiconductor and photonics technology that modern AI infrastructure…”
“We are honored to accept this award. The support from the State of Texas is critical to our expansion plans and is a tangible commitment by the state to…”
“AOI was founded by a team from the University of Houston, and over the intervening 29 years we have expanded in Texas to become a major international…”
“AOI has made great strides here in Texas, helping the world’s largest tech companies define the future of data centers with its optical networking innovation,”
“With this grant, the company can continue to expand here to manufacture the invaluable semiconductor and photonics technology that modern AI infrastructure…”
“We are honored to accept this award. The support from the State of Texas is critical to our expansion plans and is a tangible commitment by the state to…”
“AOI was founded by a team from the University of Houston, and over the intervening 29 years we have expanded in Texas to become a major international…”

The TSIF fund provides grants to higher education and state entities for research and development, and to businesses for economic development related to semiconductor design and manufacturing, aiming to solidify Texas's leadership in the industry. AOI’s 2026 expansion plans are underway to occupy an additional 210,000-square-foot manufacturing facility adjacent to its current headquarters in Sugar Land, where it will establish one of the largest production capacities for AI-focused data center transceivers in the U.S. and create over 500 new jobs in the coming years.

"Texas is leading America's resurgence in advanced manufacturing," said Governor Abbott. "This investment by AOI to expand their operations in Sugar Land will create hundreds of high-skilled jobs and advance our state's leadership in innovation and semiconductor manufacturing. The future of technological advancement will always be built in the great state of Texas."

“We are honored to accept this award. The support from the State of Texas is critical to our expansion plans and is a tangible commitment by the state to advancing semiconductor innovation for the AI era,” said Stefan Murry, Chief Financial Officer and Chief Strategy Officer, AOI. “AOI was founded by a team from the University of Houston, and over the intervening 29 years we have expanded in Texas to become a major international supplier of optical products enabling the AI age. With this investment, we can continue to expand our Texas-based capacity for production of the advanced high-speed optical transceivers that interconnect today’s AI data centers, helping cloud providers improve network performance while making their data centers more energy efficient and scalable.”

Additional Resources:

  • AOI Fact Sheet

About AOI
Applied Optoelectronics, Inc. (AOI) is a leading developer and manufacturer of advanced optical and HFC networking products that are the building blocks for AI datacenters, CATV and broadband fiber access networks around the world. AOI supplies this critical infrastructure to tier-one customers across cloud computing, CATV broadband, telecom, and FTTH markets. The company has R&D facilities in Atlanta, and R&D, engineering and manufacturing facilities at its corporate headquarters in Sugar Land, TX, as well as in Taipei, Taiwan and Ningbo, China. For additional information, visit http://newsroom.ao-inc.com.

Media contact:
Sara Cicero
sara_cicero@ao-inc.com
770-331-0269


Risks

  • Expansion plans depend on continued support and funding from state and governmental entities.
  • Potential operational risks involved in scaling up manufacturing facilities and meeting production targets.
  • Market demand for AI data center components may fluctuate, impacting future revenue and growth prospects.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026